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Abstract
Background: Coronary endarterectomy (CE) may be a good option for complete revascularization of 
diffuse coronary artery diseases, but it has not been widely used because the outcomes have not been 
definitively identified. This study aims to evaluate the mid-term clinical results of CE and compare the 
outcomes according to the use of cardiopulmonary bypass (CPB) and the surgical technique used.
Methods: Between 2004 and 2014, 69 cases of CE were performed in 64 patients. We divided the pa-
tients into two groups: 1) on-pump coronary artery bypass with coronary endarterectomy (ONCAB-CE) 
versus off-pump coronary artery bypass with coronary endarterectomy (OPCAB-CE), and 2) “open” 
versus “closed” surgical techniques. Operative mortality and major morbidity, were investigated includ-
ing perioperative myocardial infarction (PMI), and overall survival.
Results: Operative mortality was 4.7% (3/64), and no PMI was observed in the study. No statistical 
differences in operative mortality rate between the ONCAB-CE and OPCAB-CE groups were found 
(3.1% vs. 6.2%, p = 1.0) or between open versus closed techniques (6.7% vs. 2.9%, p = 0.6). The in-
cidence of major morbidity including cerebrovascular accident, atrial fibrillation, acute renal failure, 
mediastinitis, respiratory complications, and bleeding was comparable between all groups. There were 
seven late mortalities, and no differences were found in overall survival rate between all groups. 
Conclusions: Coronary endarterectomy appears to be a safe option for patients with diffuse coronary 
artery disease, regardless of whether CPB or a specified selection of surgical techniques are used.  
(Cardiol J 2017; 24, 3: 242–249)
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Introduction
With advances in percutaneous coronary in-
terventions (PCI), there has been a change in the 
spectrum of patients who are referred for coronary 
artery bypass graft (CABG) surgery. The lesions of 
coronary arteries have become more complex, and 
patients with comorbidities such as diabetes melli-
tus, dyslipidemia, and old age are being referred for 
surgical revascularization [1, 2]. In cases of diffuse 
coronary artery disease (CAD), it is not simple to 
achieve complete revascularization using routine 
CABG and incomplete myocardial revascularization 
would lead to poor short- and long-term outcomes 
after bypass surgery. 
First described by Baily et al. [3] in 1957, 
coronary endarterectomy (CE) is a method for 
treating patients with severe atherosclerotic CAD. 
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However, there is division of opinion among many 
surgeons about the safety and effectiveness of the 
technique; although proponents claim that it is the 
last option for patients with end-stage CAD [4, 5], 
opponents assert that it is associated with higher 
mortality and morbidity [6, 7]. 
There have been many studies on CE, and most 
have focused on its safety and efficacy. There is, 
however, a paucity of data regarding the influence 
of technique variations and the use of cardiopul-
monary bypass (CPB). In the present investigation 
mid-term clinical outcomes of CE were compared 
1) on-pump CABG with CE (ONCAB-CE) and off-
-pump CABG with CE (OPCAB-CE) and 2) “open” 
and “closed” endarterectomy.
Methods
Study population and clinical outcome
Between October 2004 and August 2014, 
1,215 patients underwent CABG and 64 patients 
received CE at Seoul National University Bundang 
Hospital. A total of 69 cases of CE were performed, 
and 5 patients had the CE performed in two ar-
eas. First, the 64 patients were divided into two 
groups: ONCAB-CE (n = 32) and OPCAB-CE 
(n = 32). Second, the same patients were divided 
into the two groups open (n = 30) versus closed 
(n = 34) technique. The following outcomes were 
observed : 1) operative mortality; 2) perioperative 
myocardial infarction (PMI) and major morbidity; 
and 3) overall survival.
Surgical indication and technique
Indication of CE was made intraoperatively 
either after arteriotomy revealed an occluded lu-
men with no graftable vessel or if a 1-mm coronary 
probe could not be passed down the target coronary 
vessel. The surgical techniques depended on the 
surgeon’s preference and the coronary lesion, but 
all commonly checked that the entire plaque includ-
ing branches had been removed (Fig. 1) The closed 
technique was traction of the endarterectomized 
intima through a small arteriotomy, whereas for 
the open technique, the arteriotomy was extended 
proximally and distally towards a lesser diseased 
arterial wall. In these cases, we often used an 
additional patch, such as from the saphenous 
vein or the right internal thoracic artery (RITA) 
segment, and we routinely anastomosed with 8-0 
continuous polypropylene suture. Concerning the 
use of CPB, we used OPCAB routinely, with the 
exceptions being urgent, emergency operations 
or when left ventricular (LV) dysfunction was pre-
sent, when ONCAB was used selectively. Patients 
were administered antiplatelet agents with aspirin, 
43 patients received clopidogrel in combination; 
1 patient with valve replacement surgery received 
warfarin in combination with aspirin. Four surgeons 
performed the operations.
Definitions 
Operative mortality was defined as death 
within 30 days of the surgery or death before 
discharge; LV dysfunction as LV ejection fraction 
< 40%; and respiratory complications as prolonged 
mechanical ventilation longer than 7 days or pneu-
monia confirmed pathologic organism.
We diagnosed the patients with PMI if they had 
at least two of the following four criteria:
 — prolonged (> 20 min) chest pain not relieved 
by rest or nitrates;
 — an elevated cardiac enzyme: either 1) creatine 
kinase (CK) isoform > 5% of total creatine 
phosphokinase; 2) CK greater than 2× normal; 
3) lactate dehydrogenase (LDH) subtype 1 
> LDH subtype 2; or 4) troponin > 0.2 µg/mL;
 — newly developed wall motion abnormalities;
 — serial electrocardiogram showing changes 
from baseline or serially in ST-T and/or 
Q waves that were 0.03 s in width and/or one-
third of the total QRS complex in two or more 
contiguous leads.
Postoperative acute renal insufficiency was 
defined by the following presented criteria:
 — elevated serum creatinine level > 2.0;
 — 50% or greater increase in creatinine over 
baseline preoperative value;
 — new requirement for hemodialysis.
Figure 1. Atheroma excised from the left anterior de-
scending artery (LAD) and posterolateral branch (PLB) 
in a patient.
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Review of clinical data and images
This study was conducted using a retrospec-
tive single-center design. Statistical analysis was 
performed with the SPSS software package (ver-
sion 19.0; SPSS Inc., Chicago, IL, USA); continu-
ous variables are described as mean ± standard 
deviation. Continuous variables were compared 
using Student’s t-test and the discrete variables 
with the c2-test or Fischer’s exact test; differences 
were considered significant at p < 0.05. In the 
propensity-matched cohort, all comparisons were 
tested between the groups using a paired t-test for 
the continuous variables and McNemar’s test for the 
categorical variables. To determine the independent 
risk factors for mortality, Cox’s proportional hazards 
models were used. Results are expressed as odds 
ratios with 95% confidence intervals.
This study was approved by the institutional 
review board of the documented medical institu-
tion. Informed consent was waived due to the 
retrospective nature of the study.
Results
There were more male patients in the group 
that received the open technique (p = 0.01). More 
patients were observed with LV dysfunction in the 
ONCAB-CE group (p = 0.003) and more patients 
with ascending aorta calcification in the OPCAB-CE 
group (p = 0.02). In the other preoperative 
characteristics such as age, hypertension, diabetes, 
dyslipidemia, smoking, comorbidities including 
chronic renal failure, chronic obstructive pulmo-
nary disease, peripheral arterial occlusive disease, 
and acute myocardial infarction, there were no 
significant differences between any of the groups. 
In all groups, a majority of patients had undergone 
elective surgery and had been diagnosed with triple 
vessel disease (Table 1).
In most cases, CE was conducted in the left 
anterior descending artery (67%, 43/64), and the 
bilateral internal thoracic artery (87.5%, 56/64) 
was the most frequently used. In seven patients, 
valve surgery was conducted together with CE, 
and in 3 patients, the Dor procedure was con-
ducted; in operative data, there were no signifi-
cant differences between the groups (Table 2). 
The postoperative courses were favorable; most 
patients could be extubated on the day of the sur-
gery and discharged by postoperative day 8 or 9. 
Regarding the hospital course, such as mechani-
cal ventilation time, intensive care unit stay, and 
hospital days, there were no differences between 
the groups (Table 3).
Operative mortality was 4.7% (3/64); 2 pa-
tients died due to bowel ischemia, and the other 
patient committed suicide before discharge, no 
PMI was observed in this study. There were no 
significant differences between the two groups in 
postoperative complications such as cerebral vas-
cular accident, new-onset atrial fibrillation, acute 
renal insufficiency, mediastinitis, respiratory com-
plications, and bleeding (Table 4). We performed 
propensity score matching to minimize the effects 
on the five factors in Tables 1 and 2: male sex (p 
= 0.01), ascending aortic calcification (p = 0.02), 
elective operation (p = 0.06), triple vessel disease 
(p = 0.10), and associated procedure (valve or Dor); 
a total of 28 patients were matched. Even in the 
matched cohort, no significant differences were 
found between the two groups in postoperative 
course (Table 5) or early postoperative complica-
tions (Table 6). On multivariable analysis, diabetes 
and triple vessel disease emerged as significant and 
independent risk factors for mortality (Table 7).
The average patient follow-up was 60.2 ± 33.3 
months (range: 17–134 months). There were 7 late 
mortalities in this study — 1 patient died from 
sudden cardiac arrest, 5 died of unknown causes, 
and the other died of pneumonia; the 5 unknown 
deaths included patients who had been dead on 
arrival at the emergency room and patients whose 
deaths had been confirmed by telephone survey. 
In overall survival rates, there were no significant 
differences between the groups (Fig. 2).
Discussion
The primary goal of CABG is to achieve 
complete revascularization of diseased coronary 
arteries. It has been shown that incomplete re-
vascularization is one of the most important risk 
factors associated with poor ventricular function, 
high reoperation rate, perioperative morbidity, and 
mortality [8, 9]. However, with advances in PCI, 
the lesions of coronary arteries treated surgically 
have become more calcified and complex; as such, it 
would be difficult to achieve complete revasculari-
zation using the conventional CABG in numerous 
cases with diffuse CAD.
In 1957, Baily et al. [3] first introduced the CE 
technique. However, even after half a century, the 
current opinions about the safety and effectiveness 
of CE are varied, and the technique remains contro-
versial. Although it is the only surgical technique 
that can resolve severe diffuse calcified coronary 
lesions, it can also lead to increased perioperative 
morbidity and mortality, and there are reports 
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Age [years] 68.9 ± 7.5 68.8 ± 8.1 0.96 68.7 ± 9.1 68.9 ± 6.47 0.93
Male sex 21 22 0.79 25 18 0.01
Cardiac risk factor:
Hypertension 23 21 0.59 23 21 0.20
DM 21 26 0.16 20 27 0.25
Dyslipidemia 10 18 0.44 15 13 0.34
Smoker 12 19 0.08 15 16 0.81
LV dysfunction 15 4 0.003 11 8 0.25
Comorbidities:
CRF 7 4 0.32 3 8 0.15
COPD 3 1 0.61 2 2 1.00
PAOD 7 6 0.76 4 9 0.19
AA calcification 0 5 0.02 2 3 1.00
AMI 10 10 1.00 12 8 0.16
s/p PTCA 6 10 0.25 10 6 0.15
Operative priority:
Elective 18 25 0.06 20 23 0.93
Urgent 12 6 0.10 9 9 0.75
Emergent 2 1 1.00 1 2 1.00
Diseased vessels:
1 VD 0 2 0.49 0 2 0.49
2 VD 1 4 0.36 4 1 0.18
3 VD 31 26 0.10 26 31 0.70
ONCAB-CE — on–pump coronary artery bypass coronary endarectomy; OPCAB-CE — off–pump coronary artery bypass coronary endarectomy; 
DM — diabetes mellitus; LV — left ventricle; CRF — chronic renal failure; COPD — chronic obstructive pulmonary disease; PAOD — peripheral  
arterial occlusive disease; AA — ascending aorta; AMI — acute myocardial infarction; PTCA — percutaneous transluminal coronary angioplasty; 
VD — vessel disease










Target vessel [total 69 sites]:
LAD (D) 19 24 0.44 22 21 0.69
LCx (OM) 5 4 0.73 5 4 0.73
RCA (PDA/PLb) 9 8 0.63 7 10 0.44
Used graft [total 69 sites]:
LITA 15 20 0.40 17 18 0.91
RITA 9 12 0.59 13 8 0.17
RA 1 0 0.48 0 1 1.00
SVG 8 4 0.15 4 8 0.22
Total number of distal anastomosis 3.7 ± 1.0 3.2 ± 1.1 0.13 3.6 ± 1.1 3.3 ± 1.0 0.31
Associated procedure:
MVP or MAP 6 0 4 2 0.41
AVR 1 0 1 0 0.47
Dor procedure 3 0 1 2 1.00
ONCAB-CE — on–pump coronary artery bypass coronary endarectomy; OPCAB-CE — off–pump coronary artery bypass coronary endarectomy; 
LAD — left anterior descending artery; D — diagonal artery; LCx — left circumflex artery; OM — obtuse marginal artery; RCA — right  
coronary artery; PDA — posterior descending artery, PLb — posterolateral branch; LITA — left internal thoracic artery; RITA — right internal 
thoracic artery; RA — radial artery; SVG — saphenous vein graft; MVP — mitral valve plasty; MAP — mitral annuloplasty; AVR — aortic valve 
replacement
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that it is not advantageous to long-term survival 
[6, 7, 10].
Studies show the mortality after CE to be 0% 
to 15% [6, 11–13]. These could be seen as high 
rates compared with the results of conventional 
CABG only, but it could be said that rather than 
the technique itself being dangerous, the patients 
who receive CE already have high comorbidities 
and risk factors; in fact, the total CABG mortality 
during the same period in our hospital was 5.1% 
(62/1215), showing no significant difference sta-
tistically. For PMI, which is known to be one of 
the biggest complications of CE, mortality is also 
reported as ranging from 0% to 15% [11–14]. How-
ever, the incidence of PMI is gradually decreasing 
because of improvements in surgical techniques 










Ventilator time [h] Mean ± SD 18.8 ± 30.3 12.7 ± 14.2 0.31 14.0 ± 13.6 17.3 ± 30.0 0.58
Median (range) 13.8 (1.0–174) 4.8 (1.5–33) 12.0 (1.0–68.5) 7.3 (1.5–174)
ICU stay [h] Mean ± SD 84.6 ± 208.4 37.6 ± 29.8 0.21 43.3 ± 33.1 76.9 ± 202.9 0.37
Median (range) 38.8 (9–1183) 23.4 (14–312) 28.0 (15–164) 24.3 (9–1183)
Hospital stay [day] Mean ± SD 26.3 ± 59.8 12.1 ± 11.8 0.20 15.0 ± 17.4 22.9 ± 57.3 0.47
Median (range) 8.5 (6–337) 8 (4–25) 8.5 (5–99) 8 (4–337)
ONCAB-CE — on–pump coronary artery bypass coronary endarectomy; OPCAB-CE — off–pump coronary artery bypass coronary endarectomy; 
ICU — intensive care unit; SD — standard deviation










Operative mortality 1 2 1.00 2 1 0.60
Perioperative MI 0 0 0 0
Cerebrovascular accident 1 0 1.00 0 1 1.00
Atrial fibrillation 7 4 0.32 6 5 0.58
Acute renal failure 3 2 1.00 2 3 1.00
Mediastinitis 1 0 1.00 1 0 0.47
Respiratory complication 1 1 1.00 0 2 0.49
Bleeding 2 0 0.49 0 2 0.49
ONCAB-CE — on–pump coronary artery bypass coronary endarectomy; OPCAB-CE — off–pump coronary artery bypass coronary endarectomy; 
MI — myocardial infarction










Ventilator time [h] Mean ± SD 25.5 ± 44.5 9.1 ± 8.4 0.188 8.8 ± 8.6 22 ± 39.6 0.312
Median (range) 12.5 (1–174) 4.8 (1.5–24.5) 5.5 (1–29.6) 8.5 (1.5–174)
ICU stay [h] Mean ± SD 124.4 ± 306.9 51 ± 78.4 0.394 34.6 ± 28.2 117.2 ± 275.6 0.358
Median (range) 23 (15–1183) 22.8 (15–312) 20.5 (15–94) 24 (15–1183)
Hospital stay [day] Mean ± SD 36.2 ± 88.1 11.8 ± 5.7 0.319 9.8 ± 3.6 31.9 ± 77.5 0.380
Median (range) 8 (6–337) 11 (5–21) 8 (6–16) 9.5 (5–337)
ONCAB-CE — on–pump coronary artery bypass coronary endarectomy; OPCAB-CE — off–pump coronary artery bypass coronary endarectomy; 
ICU — intensive care unit; SD — standard deviation
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Operative mortality 0 1 1 0 1 1
Perioperative MI 0 0 – 0 0 –
Cerebrovascular accident 1 0 1 0 1 1
Atrial fibrillation 2 2 1 1 3 1
Acute renal failure 1 1 1 0 2 0.524
Mediastinitis 0 0 – 0 0 –
Respiratory complication 1 1 1 0 2 0.524
Bleeding 1 0 1 0 1 1
ONCAB-CE — on–pump coronary artery bypass coronary endarectomy; OPCAB-CE — off–pump coronary artery bypass coronary endarectomy; 
MI — myocardial infarction
Table 7. Multivariable analysis for risk factors of mortality after coronary endarterectomy.
Predictor Univariate OR  
(95% CI)
P Multivariate OR  
(95% CI)
P
Age 1.04 (0.95–1.15) 0.362 1.08 (0.92–1.20) 0.152
Gender 1.61 (0.45–5.72) 0.466
Hypertension 1.42 (0.40–5.06) 0.584
Diabetes mellitus 4.45 (1.25–15.82) 0.021 13.62 (1.55–119.98) 0.019
Dyslipidemia 0.92 (0.27–3.21) 0.901
Smoker 2.79 (0.72–10.88) 0.139
Left ventricular dysfunction 1.42 (0.30–6.73) 0.657 1.28 (0.22–7.37) 0.783
Chronic renal failure 1.80 (0.23–14.23) 0.577
Chronic obstructive pulmonary disease 0.53 (0.07–4.26) 0.552
Peripheral arterial occlusive disease 2.27 (0.29–18.05) 0.437
Ascending aortic calcification 0.95 (0.12–7.56) 0.962
Acute myocardial infarction 37.64 (0.15–9782.31) 0.201
Percutaneous coronary intervention 3.01 (0.38–23.83) 0.297
Emergent operation 0.45 (0.06–3.62) 0.454 0.07 (0.01–1.10) 0.058
Triple vessel disease 3.82 (0.99–14.82) 0.053 37.56 (3.30–427.28) 0.003
OR — odds ratio; CI — confidence interval 
and added myocardial protection techniques, and 
no PMI were observed in this study. 
The achievement of OPCAB with good results 
has encouraged surgeons to perform endarter-
ectomy on beating hearts, and recent studies on 
OPCAB-CE showed favorable outcomes [15–17]. 
In these studies, OPCAB-CE was feasible and 
could be performed in patients with LV dysfunc-
tion who were expected to benefit from complete 
revascularization. In addition to, in the current 
study, the outcomes were examined of patients who 
underwent CE with either on- or off-pump CABG. 
Naseri et al. [18] reported that OPCAB-CE can 
be performed safely with morbidity and mortality 
comparable with those of ONCAB-CE.
In this study, half the total number or 32 pa-
tients received OPCAB-CE. The total operative 
mortality of CE in this study was 4.7% (3/64), 
which was comparable with findings of previous 
studies. We prefer ONCAB in patients with LV 
dysfunction but OPCAB in patients with ascending 
aortic calcification, and thus, there were differ-
ences in these two preoperative characteristics 
between the two groups. The 10 ONCAB-CE 
patients with a valve disease and concomitant 
LV aneurysm procedure could have affected our 
results. There was a limitation of small sample 
size in this study, thus propensity score match-
ing was performed so that similar results could 
be described. 
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Figure 2. A, B. Kaplan-Meier curves for overall survival comparing (1) on-pump coronary artery bypass grafting with 
closed endarterectomy (CE) (ONCAB-CE) and off-pump coronary artery bypass grafting with CE (OPCAB-CE), and 
(2) open and CE.
As already noted, CE can be conducted in two 
ways, either open or closed. The open technique 
is with arteriotomy extended proximally and 
distally towards a lesser diseased arterial wall. 
In contrast, the closed technique entails traction 
of the endarterectomized intima through a small 
arteriotomy. The open technique sometimes uses 
the saphenous vein or remnant RITA segment to 
perform an on-lay patch angioplasty; this has the 
advantage that the obstruction or flap inside the 
native coronary artery can be checked, but this 
surgery takes a long time and the bleeding risk is 
increased. The closed technique is also called the 
traction technique, and it has the advantage that 
operation time is short and concise, but there is 
the possibility of an obstruction and intimal flap 
that cannot be completely ruled out with this op-
eration. Nishi et al. [14] compared the closed and 
on-lay patch bypass techniques and showed that 
there was no difference between the two groups 
in terms of perioperative mortality and morbid-
ity, but they did note that the on-lay patch bypass 
group had better mid-term angiographic results. 
However, that study was different from this one 
as all patients received conventional CABG using 
CPB and cardioplegia. 
Many studies have evaluated graft patency 
after CE, and the patency rate has been reported 
as occurring in 80–98.6% of cases [14, 19, 20]; 
these studies report on the mid-term or long-term 
patency from coronary angiography (CAG). In this 
study there was an attempt to evaluate the mid-
term patency of CE, but postoperative computed 
tomographic angiography (CTA) was performed 
in only 58% of the patients. In most of the cases 
in which CTA was not conducted, there were 
limitations in using contrast due to accompanying 
chronic kidney disease, and in the remaining cases, 
patients refused to participate in the postoperative 
study; in this limited study, the interval was 5.5 ± 
± 2.4 months. Thirty-eight sites were patent among 
the 41 (92.7%) vessels, and there was no difference 
in the mid-term patency between the open and 
closed technique groups (22/23, 95.7% vs. 16/18, 
88.9%; p = 0.41) or between the ONCAB-CE 
and OPCAB-CE groups (21/24, 87.5% vs. 17/17, 
100%; p = 0.25). 
Unlike previous studies, our study used CTA 
to measure the patency of CE. In the presented 
hospital, postoperative coronary CTA was routinely 
conducted rather than CAG because it is less inva-
sive. In addition, graft patency can be accurately 
estimated using CTA because the graft is less in-
fluenced by cardiac motion, the graft diameter is 
large, and there is very little calcification. CTA is 
also relatively widely used in South Korea because 
of national health insurance policy.
There are a number of limitations in this study. 
First, the study was conducted retrospectively, and 
second, we lacked a control group. Finally, a rela-
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tively small number of patients were enrolled, and 
results are based on a mid-term follow-up. Thus, 
a large number of patients and long-term follow-
up periods are needed for more complete results.
Conclusions
This study revealed that CE can be a good 
option for achieving complete myocardial revas-
cularization in selected patients with diffuse CAD. 
Also, CE may be performed securely with accept-
able outcomes, regardless of whether CPB is used 
or selection of the surgical techniques.
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